Protara Therapeutics Company

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Technology: Cell therapy
Industry: Private, Small&Large Molecules
Headquarters: New York, New York, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 1
Total Funding: 4150000
Last Funding Date: 2022-05-20
Last Funding Type: Seed

Visit Website
info@protaratx.com
Register and Claim Ownership